Align Technology, Inc. (NASDAQ: ALGN) continues to be an active player in the
bio-tech arena. In recent months, the stock's performance was influenced by various factors, including its underlying
fundamentals. The
National Bank of Canada FI increased its shareholdings in ALGN. However, insiders at the company sold off US$8.4 million in stock, which could be an indication of the potential weakness in the market. Despite losses on certain days, the stock outperformed the general market on several occasions, reflecting a degree of resiliency. The
Options Market predicts a spike in ALGN stock. In
Q3 2024, Align Technology's earnings surpassed estimates. The company announced a
$275 Million Open Market Repurchase but missed its revenue target for the quarter. Align's stock has been negatively impacted by macroeconomic issues and foreign exchange headwinds. In recent, positive developments include securing EU & UK Approval for its
3D-Printed Invisalign Expander. In spite of mixed earnings reports, the stock's target price was set based on rebound potential.
Align Technology ALGN News Analytics from Wed, 24 Apr 2024 07:00:00 GMT to Sat, 14 Dec 2024 12:07:48 GMT -
Rating 2
- Innovation 3
- Information 5
- Rumor -1
